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Abstract
Scrub typhus is a febrile infection caused by the obligate intracellular bacterium Orientia tsu-
tsugamushi, which causes significant morbidity and mortality across the Asia-Pacific region.
The control of this vector-borne disease is challenging due to humans being dead-end
hosts, vertical maintenance of the pathogen in the vector itself, and a potentially large rodent
reservoir of unclear significance, coupled with a lack of accurate diagnostic tests. Develop-
ment of an effective vaccine is highly desirable. This however requires better characteriza-
tion of the natural immune response of this neglected but important disease. Here we
implement a novel IFN-γ ELISpot assay as a tool for studying O. tsutsugamushi induced cel-
lular immune responses in an experimental scrub typhus rhesus macaque model and
human populations. Whole cell antigen for O. tsutsugamushi (OT-WCA) was prepared by
heat inactivation of Karp-strain bacteria. Rhesus macaques were infected intradermally with
O. tsutsugamushi. Freshly isolated peripheral blood mononuclear cells (PBMC) from
infected (n = 10) and uninfected animals (n = 5) were stimulated with OT-WCA, and IFN-γ
secreting cells quantitated by ELISpot assay at five time points over 28 days. PBMC were
then assayed from people in a scrub typhus-endemic region of Thailand (n = 105) and
responses compared to those from a partially exposed population in a non-endemic region
(n = 14), and to a naïve UK population in UK (n = 12). Mean results at Day 0 prior to O.
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tsutsugamushi infection were 12 (95% CI 0–25) and 15 (2–27) spot-forming cells (SFC)/106
PBMC for infected and control macaques respectively. Strong O. tsutsugamushi-specific
IFN-γ responses were seen post infection, with ELISpot responses 20-fold higher than
baseline at Day 7 (mean 235, 95% CI 200–270 SFC/106 PBMC), 105-fold higher at Day 14
(mean 1261, 95% CI 1,097–1,425 SFC/106 PBMC), 125-fold higher at Day 21 (mean 1,498,
95% CI 1,496–1,500 SFC/106 PBMC) and 118-fold higher at Day 28 (mean 1,416, 95% CI
1,306–1,527 SFC/106 PBMC). No significant change was found in the control group at any
time point compared to baseline. Humans from a scrub typhus endemic region of Thailand
had mean responses of 189 (95% CI 88–290) SFC/106 PBMC compared to mean
responses of 40 (95% CI 9–71) SFC/106 PBMC in people from a non-endemic region and 3
(95% CI 0–7) SFC/106 PBMC in naïve controls. In summary, this highly sensitive assay will
enable field immunogenicity studies and further characterization of the host response to O.
tsutsugamushi, and provides a link between human and animal models to accelerate vac-
cine development.
Author summary
Scrub typhus is a disease caused by bacteria that invade cells in our immune system and
blood vessels. It is transmitted by mites and is treatable with antibiotics. Unfortunately
diagnosis is difficult and requires techniques that are not easily accessible everywhere.
Currently, there is no scrub typhus vaccine available. In order to improve diagnostics and
vaccine development in future, we need to better understand our immune response
against these bacteria. In this study, we developed a test where these bacteria were killed
and prepared by a new purification method to stimulate the immune cells in our blood
-not antibodies. We evaluated this test in hospitalized patients with scrub typhus disease
and also in non-human primates to study the responses over time. The test proved to be
very accurate and useful to study natural immune responses, and we found differences in
responses in areas where scrub typhus is common, compared to areas where it is not com-
mon. This test will allow us to investigate the immune response to scrub typhus more in-
depth in the future, and will support the development of better diagnostic tests and vac-
cines against scrub typhus.
Introduction
Scrub typhus is a zoonotic illness caused by the intracellular bacterium Orientia tsutsugamushi
which is endemic mainly across the Asia-Pacific region [1]. The pathogen is transmitted by the
bite of larval Trombiculid mites known as chiggers [2, 3]. Scrub typhus is a febrile illness with
a wide spectrum of disease severity from mild febrile illness to potentially fatal illness influ-
enced by O. tsutsugamushi strains and host immune status. The specific skin lesion, known as
an eschar, has been reported up to 68% of Thai patients with scrub typhus [4]. The disease is
treatable by antibiotics such as doxycycline, tetracycline or chloramphenicol [5], although
emergence of antibiotic resistant strains has been reported in northern Thailand [6]. If
untreated, the mortality is around 6% [7]. Awareness of and research into scrub typhus has
been limited by its non-specific symptoms and difficulty of diagnosis, and a vaccine is highly
desirable [8, 9].
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A greater understanding of the host immune response to O. tsutsugamushi is required for
vaccine design. As an obligate intracellular pathogen, cellular immunity is likely to be neces-
sary for host control of infection. Several studies have reported a role for type 1 cell mediated
immunity and specifically IFN-γ production in response to O. tsutsugamushi for immune pro-
tection against infection. Increased levels of IFN-γ and other type 1 cytokines are seen in the
blood of patients with scrub typhus compared to controls [10–13]. Adoptive transfer experi-
ments of monocyte-depleted splenocytes [14] and antigen-specific IFN-γ T-cells in murine
models [15] have supported an important role for cell mediated immunity in protection
against death from scrub typhus. Replication of O. tsutsugamushi inside macrophages is
impaired by extrinsic IFN-γ [16]. O. tsutsugamushi infected monocyte-derived dendritic cells
induce production of IFN-γ from CD4+ T-cells [17]. Scrub typhus is universally fatal in
CD8-deficient mice (compared to 50% fatality in wild type mice) [18], and CD8+ T-cells play
a vital protective role in control of O. tsutsugamushi growth [19]. In humans, CD8+ T-cell pro-
liferation was seen during the convalescent phase of scrub typhus in patients [20]. These stud-
ies suggest the importance of developing a reliable method of monitoring O. tsutsugamushi-
specific IFN-γ responses during scrub typhus.
The enzyme-linked immunospot (ELISpot) assay is a very sensitive technique allowing
quantification of antigen-specific T-cells at the single cell level from peripheral blood by detec-
tion of IFN-γ or other secreted cytokines [21, 22]. The ex-vivo IFN-γ ELISpot assay is the most
widely used technique for monitoring T-cell-based immune responses against intracellular
pathogens such as HIV [23], tuberculosis [24] and malaria [25]. There are several advantages
of the ELISpot assay for use in clinical trials: it has high sensitivity, is relatively easy to perform,
uses low number of cells in the assay, does not require expensive instrumentation, and has the
potential for high throughput screening with numerous specific peptides, or to an entire path-
ogen proteome using overlapping peptides of varying lengths. The ELISpot is up to 200 times
more sensitive for cytokine detection than ELISA [26, 27] and significantly more sensitive
than flow-cytometric based techniques [28].
Non-human primates (NHP) represent a model for investigating immunity to scrub typhus
and provide valuable information to develop potential candidate vaccines for future testing in
the clinical setting. Infection of cynomolgus macaques (Macaca fascicularis) with O. tsutsuga-
mushi causes infection and illness which closely resemble the course of scrub typhus in
humans [29, 30]. Due to some limitations of using cynomolgus macaques, such as reagent and
antibody availability, the rhesus macaque (Macaca mulatta) is likely to be more suitable for
preclinical vaccine evaluation.
In this study, we developed a novel ex-vivo IFN-γ ELISpot assay using whole cell antigen of
O. tsutsugamushi (OT-WCA) as an antigen to determine magnitude and frequency of cellular
responses in peripheral blood mononuclear cells (PBMC) of rhesus macaques. Our results
indicate that our ex-vivo IFN-γ ELISpot assay can be used to determine immune responses
against O. tsutsugamushi with high sensitivity and potentially high specificity for evaluation of
vaccine candidate efficacy against O. tsutsugamushi in rhesus macaques and human clinical
trials.
Materials and methods
Ethics statement
All animal research was performed strictly under approved IACUC protocol by the Institu-
tional Animal Care and Use Committee and Biosafety Review Committee at the Armed Forces
Research Institute of Medical Sciences (AFRIMS) Bangkok, Thailand, an AAALAC Interna-
tional-accredited facility. The IACUC protocol numbers are: PN12-01 (approved 31st Jan
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2012), and PN13-12 (approved 24th Jan 2014). The animal research was conducted in compli-
ance with Thai laws, the Animal Welfare Act, and all applicable U.S. Department of Agricul-
ture, Office of Laboratory Animal Welfare and U.S. Department of Defense guidelines. All
animal research adhered to the Guide for the Care and Use of Laboratory Animals, NRC Pub-
lication (8th Edition) [31].
Animals were housed individually in standard squeeze-type stainless steel cages with a min-
imum floor space of 4.4 square feet equipped with standard enrichments and exposed to ambi-
ent environmental conditions inside an Animal Biosafety Level 3 (ABSL-3) containment
laboratory. Monkeys were fed daily with commercially prepared old-world primate extruded
feed and supplemented with fresh fruit or vegetable four times per week. Fresh chlorinated
water (5–10 ppm) was provided ad libitum via automatic water valves. Cages were cleaned
daily and sanitized biweekly. All procedures were performed under anesthesia using ketamine
hydrochloride, and all efforts were made to minimize stress, improve housing conditions, and
to provide enrichment opportunities. Animals were euthanized by ketamine hydrochloride
injection followed by barbiturate in accordance with the Guidelines for the Euthanasia of Ani-
mals (2013 Edition of the American Veterinary Medical Association).
The O. tsutsugamushi Karp strain (New Guinea) used in this study was provided by the
Naval Medical Research Center (NMRC), Silver Spring, MD, USA and is a well-characterized
strain from a pre-existing collection of Orientia strains at the NMRC, previously used in
related studies [30, 32].
Non-human primate model
Fifteen (9 male and 6 female) Indian-origin rhesus macaques (M. mulatta housed in
AFRIMS (an AAALAC-accredited Program) were used in this study. Environmental condi-
tions were maintained in accordance with the Guide for the Care and Use of Laboratory Ani-
mals 8th edition (2011) [31]. The animals ranged from 3 to 5 year of age and weighed
between 4.1 and 5.9 kg at the start of the study. The animals were evaluated to ensure that
they were negative from SIV, SRV, STLV-1 and herpes B virus and had no O. tsutsugamushi
exposure from the experimental history. Additionally, their antibody titers to O. tsutsugamu-
shi were confirmed negative prior to start the experiment. Aliquots of inoculum containing
defined concentrations of O. tsutsugamushi Karp strain at a dose of either 107 or 107.8
muLD50 (cultured and prepared in yolk sacs of chicken eggs), were used for intradermal (ID)
injections of a total of 10 macaques. The inoculum was prepared in collaboration with the
Mahidol-Oxford Tropical Medicine Research Unit (MORU) and the Naval Medical Research
Center (NMRC), Silver Spring, Maryland, USA. The dosages were administered in infected
groups on day 0. The inoculum was suspended in 100 μl of Snyder’s buffer and was applied
to the anterior medial aspect of the left thigh. A total of 5 macaques were used as control
group. The control macaques received ID injection with homogenized un-infected inocula
in Snyder’s buffer at the identical site on the anterior medial aspect of the left thigh. Blood
samples for PBMC isolation were collected at 5 time points starting from Day 0 prior to ID
inoculation and every week up to Day 28. Bacteremia was determined using a previously
describes qPCR assay for O. tsutsugamushi-specific 47 kDa gene [33]. DNA was extracted
from 200 μl whole blood from each macaque using DNeasy Blood & Tissue Kit (Qiagen,
Valencia, CA, USA) according to the manufacturer’s instructions. The O. tsutsugamushi-spe-
cific 47 kDa htra gene real time PCR assay was used as previously described using a CFX96
Real Time PCR Detection System (Biorad, Hercules, CA “no template” negative controls
were run with each reaction and plasmid DNA served for standard curves in serial dilution
from 106 to 1 copies/μl of 47 kDa gene [34].
Scrub typhus cellular immunity via Elispot assay
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Peripheral blood mononuclear cell (PBMC) isolation
PBMC were separated from 12 ml heparinized blood samples by density centrifugation within
3 hours of blood draw. In brief, 3 ml of Ficoll-HyPaque gradients (Pharmacia, Peapack, NJ)
was preloaded in a 14 ml LeucoSep tube (Greiner Bio-One) by centrifugation for 1 min at
1,000 × g. The whole blood was added to the LeucoSep tube and centrifuged for 15 min at 800
× g without braking at room temperature. The cell suspension was collected, and the cells were
washed twice in complete RPMI medium [RPMI 1640 (Sigma-Aldrich, St. Louis, MO) con-
taining 10% FBS (Invitrogen Corp., Carlsbad, CA), 2 mM L-glutamine, 50 U/ml gentamicin
(Quality Biological Inc., Gaithersburg, MD), and 0.1 mM non-essential amino acids (Sigma-
Aldrich, St. Louis, MO)] for 5 min at 640 and 7 min at 470 × g, respectively. After final wash-
ing, the pellet was resuspended in complete RPMI medium before counting.
Preparation of O. tsutsugamushi whole cell antigen (OT-WCA) for
ELISpot assay
The O. tsutsugamushi Karp strain was cultivated in L929 cells (mouse fibroblast cell line) cul-
tured in RPMI1640 supplemented with 10% fetal bovine serum (FBS) and 2 mM L-glutamine.
The stage of infection was determined by indirect immunofluorescence assay (IFA); when
infected L929 cells approached 100% positive infection, the cells were harvested by centrifuga-
tion at 6,000 x g for 30 min at 4˚C. The cells were pelleted and disrupted using glass beads (0.1
mm, Next Advance, Averill Park, NY), then homogenized with a bullet blender for 1 min.
After centrifugation at 300 x g for 10 min to remove cell debris, the supernatant was collected
and filtered through a 2.0 μm syringe filter. The supernatant was then centrifuged at 11,000 x g
for 10 min to collect the bacterial pellet. After washing the pellet with PBS, the bacteria were
resuspended in 50 μl PBS and heated at 80˚C for 1 hour. The OT-WCA suspension was then
aliquoted and stored at 4˚C until used, with immunogenicity of the antigen confirmed up to
five years of storage. The total protein concentration of OT-WCA protein was determined by
BCA assay (BCA1 kit, Sigma-Aldrich, St. Louis, MO). All processes were performed in a bio-
safety level 3 laboratory. The protein concentration for the OT-WCA used in this study was
1.41 mg/ml. Phytohemagglutinin (PHA) was used at a final concentration of 5 μg/ml and
RPMI containing 10% FCS (termed ‘complete RPMI’) was added to positive control wells and
negative wells, respectively.
Ex-vivo interferon-gamma (IFN-γ) enzyme-linked immunospot (ELISpot)
assay
The kinetics and magnitude of the cellular responses to whole O. tsutsugamushi were assessed
by ex-vivo IFN-γ ELISpot following an 18 hour stimulation of PBMC with OT-WCA for each
time point of the study. Fresh PBMC were used in all ELISpot assays, and separate ELISpot
kits (Mabtech, AB, Sweden) for human (3420-2A) and monkey (3421M-2A) cells were used.
Briefly, 96-well Multiscreen-I plates (Millipore, UK) were coated for 3 hours with 10 μg/ml
GZ-4 anti-human IFN-γ (Mabtech, AB, Sweden) at room temperature. Fresh PBMC were
added in duplicate wells at 2x105 PBMC in 50 μl per well and 50 μl of OT-WCA was added at
the optimal concentration. For human studies, a T-cell epitope pool (Mabtech, AB, Sweden) at
a final concentration of 1 μg/mL was used as control antigens. After 18 hours, secreted IFN-γ
was detected by adding 1 μg/ml biotinylated mAb 7-B6-1-biotin for IFN-γ, which recognises
an epitope completely conserved between human and macaques in the helical region of
human IFN-γ, (Mabtech, AB, Sweden) for 3 hours and followed by 1 μg/ml streptavidin alka-
line phosphatase (Mabtech, AB, Sweden). The plates were developed using the AP Conjugate
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Substrate Kit (Biorad, USA) according to the manufacturer’s instructions. ELISpot plates were
scanned using a CTL ELISpot reader (Cellular Technology Limited, USA). Spots were then
counted by Immunospot 3.1 software, using the manufacturer’s automated SmartCount™ set-
tings. Results were expressed as IFN-γ spot-forming cells (SFC) per million PBMC. Back-
ground responses in unstimulated control wells were always less than 20 spots/106 PBMC, and
were subtracted from those measured in OT-WCA stimulated wells.
Human samples
The recruitment of human subjects for immunological studies has been described previously
in a study of melioidosis [35]. PBMC were isolated from subjects in Ubon Ratchathani, (north-
eastern Thailand—an endemic area for scrub typhus), Bangkok, (central Thailand—a non-
endemic for scrub typhus) and Oxford, UK (non-endemic for scrub typhus) participating in a
study of melioidosis. Responses to O. tsutsugamushi were evaluated using the same ex vivo
IFN-γ ELISpot assay, with PBMC from Ubon Ratchathani subjects known to known to be
reactive to OT-WCA used in Oxford as positive controls.
Indirect immunofluorescence assay (IFA)
Human anti-Orientia antibodies (IgM/IgG) were detected using IFA for scrub typhus, based
on pooled whole-cell antigens from three strains of O. tsutsugamushi (Karp, Kato and Gilliam
strains) as previously described [36]. IFN-γ ELISpot responses were compared for people with
IFA IgG titers of 1:400 compared to those with titres < 1:400.
Statistical analysis
Statistical analyses were performed using GraphPad Prism Software v. 6. The results between
the control group versus the infected group are expressed as means and were compared using
the non-parametric Mann-Whitney U- test. Significant differences between timepoints within
a group were determined with the non-parametric Wilcoxon t-test. The relationship between
IFN-γ ELISpot responses and IFA IgG titers was evaluated using Spearman’s rank correlation
test. Two-tailed P values less than 0.05 were considered significant.
Results
Optimization of O. tsutsugamushi whole cell antigen (OT-WCA)
concentration for use in an ex-vivo IFN-γ ELISpot assay
Frozen PBMC from rhesus macaques collected at Day 14 post inoculation (pi) with O. tsutsu-
gamushi (BRI-02) and from a control uninfected macaque (BRI-06) were stimulated in
duplicate with 50 μl of OT-WCA prepared at 3 different concentrations: 1.41 (1:50 dilution),
0.71 (1:100) and 0.14 (1:500) μg/well. PHA and ‘complete media’ were used as positive and
negative controls respectively, (Fig 1 and Table 1). Strong IFN-γ ELISpot responses to
OT-WCA were observed in infected macaques, whereas no responses to OT-WCA was
observed in the uninfected macaque. Strong responses to PHA stimulation were found in
positive control wells (Fig 1 and Table 1). Concentrations of OT-WCA above 1.41 μg/well
were not tested because a blackout of the spot count was likely, and the optimized 0.14 μg/
well concentration was selected for OT-WCA for the stimulation in further testing of experi-
mental macaques.
Scrub typhus cellular immunity via Elispot assay
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Kinetics and magnitude of cellular immune responses over time with ex-
vivo IFN-γ ELISpot
The O. tsutsugamushi-specific cellular immune responses were measured with ex-vivo IFN-γ
ELISpot assay from fresh isolated PBMC of rhesus macaques at five time points after O. tsutsu-
gamushi infection (Day 0, 7, 14, 21 and 28) to study the kinetics and magnitude of the
responses over time (Fig 2). Freshly isolated PBMC from each macaque was tested in duplicate
with OT-WCA at 0.14 μg/well. Each well contained 2x105 PBMC, and SFCs were quantitated
by the CTL ELISpot reader—therefore responses were multiplied by 5 to provide SFC / million
PBMC. Strong responses were found from PHA stimulated wells in all macaques, and back-
ground responses assessed by media only were always less than 20 SFC/106 PBMC (Table 2).
Specific responses to O. tsutsugamushi were calculated by subtraction of corresponding media
only wells from OT-WCA. Wells with very high responses resulted in blackout of the spot
count and are represented as 300 spots (1,500 SFC/106 PBMC), corresponding to the highest
spot count that can be measured by CTL ELISpot reader in our experiment. Overall, O. tsutsu-
gamushi-specific IFN-γ responses were observed from all infected macaques.
At Day 7, the response to OT-WCA from infected macaques (mean 235 SFC/106, 95% CI
200–270 SFC/106) was 20-fold higher than baseline level (Day 0; mean 12 SFC/106 and 95% CI
Fig 1. Ex-vivo IFN-γ ELISpot responses to O. tsutsugamushi whole-cell antigen (OT-WCA) using frozen PBMCs of rhesus macaques. Plate
readout of ex-vivo IFN-γ ELISpot responses to OT-WCA from frozen PBMC of rhesus macaques 28 days after infection with 106 O. tsutsugamushi (left)
and non-infected control macaques (right) at 3 concentrations of 1.41 μg (dilution of 1:50), 0.71 μg (1:100) and 0.14μg (1:500) per well. PHA and
‘media’ are positive and negative control, respectively.
https://doi.org/10.1371/journal.pntd.0005846.g001
Table 1. Optimization of the ex vivo IFN-γ ELISpot assay.
Adjusted IFN-γ Spot Count (SFC/106 PBMC)
OT infected Controls
Well #1 Well #2 Mean 95%CI Well #1 Well #2 Mean 95%CI
PHA 155 195 175 (0–429) 440 405 422.5 (200–645)
Media 0 0 0 (0–0) 10 0 5 (0–69)
OT 1.41 μg 805 990 897.5 (0–207) 0 5 2.5 (0–34)
OT 0.705 μg 740 740 740 (740–740) 10 0 5 (0–69)
OT 0.141 μg 655 565 610 (38–1182) 15 5 10 (0–34)
Note: Spot counts are expressed as spot forming cells per million peripheral blood mononuclear cells (SFC/106 PBMC).
https://doi.org/10.1371/journal.pntd.0005846.t001
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0–25 SFC/106). At Day 14 the specific IFN-γ responses rose>100-fold (mean 1,261 95% CI
1,097–1,425 SFC/106 PBMC), and were 125-fold higher at Day 21 (mean 1,498, 95% CI 1,496–
1,500 SFC/106 PBMC) and 118-fold higher at Day 28 (mean 1,416, 95% CI 1,306–1,527 SFC/
106 PBMC). No change in specific IFN-γ response to O. tsutsugamushi was found for unin-
fected control macaques. An overview of the adjusted spots count is shown in Table 2.
Fig 2. Cellular immune response kinetics by ex-vivo IFN-γ ELISpot. The kinetics of the cellular immune responses measured by ex-vivo
IFN-γ ELISpot to OT-WCA after ID infection with O. tsutsugamushi (Infected, n = 10) versus mock injection (Control, n = 5) in rhesus
macaques (panel A). *** = statistically significant difference (P 0.001) between Infected and Control groups by non-parametric Mann-
Whitney U- test. Data plotted as means with 95% confidence intervals.
https://doi.org/10.1371/journal.pntd.0005846.g002
Table 2. Adjusted spot counts from ex-vivo IFN-γ ELISpot at each time point.
Adjusted spot count (SFC/106 PBMC)
Days after
infection
Control macaques (n = 5) O. tsutsugamushi infected macaques (n = 10)
1 2 3 4 5 Mean 6 7 8 9 10 11 12 13 14 15 Mean
Day 0 7.5 12.5 7.5 12.5 32.5 14.5 0 15 2.5 12.5 10 12.5 7.5 17.5 15 25 11.75
Day 7 2.5 22.5 10 0 12.5 9.5 262.5 232.5 192.5 252.5 262.5 212.5 240 302.5 267.5 125 235
Day 14 7.5 30 0 0 55 18.5 1250 1392.5 1500 1500 997.5 1342.5 1245 1497.5 882.5 1005 1261.25
Day 21 0 27.5 0 0 22.5 10 1497.5 1500 1500 1495 1500 1500 1492.5 1497.5 1497.5 1500 1498
Day 28 22.5 25 7.5 15 0 14 1497.5 1500 1497.5 1577.5 1080 1480 1480 1310 1247.5 1495 1416.5
Values represent the mean SFC/106 PBMC count from cellular immune responses to OT-WCA after subtraction of the background response (complete
media) after ID administration of live O. tsutsugamushi (n = 10) versus mock (n = 5) in rhesus macaques.
https://doi.org/10.1371/journal.pntd.0005846.t002
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Relationship between IFN-γ ELISpot response, IFA titer and
bacteraemia in the non-human primate model
We explored the relationship in the macaque model between ex-vivo IFN-γ ELISpot of cellular
immune responses to O. tsutsugamushi and antibody responses to O. tsutsugamushi as mea-
sured by an IgG and IgM IFA assay. We saw a correlation between the magnitude of the cellu-
lar response and the reciprocal titers of the IgG-based IFAs in the non-human primate model
(r 0.79 = P < 0.001 by Spearman’s rank test) (Fig 3, panel A). A significant correlation was not
seen for each individual time point. This may be because there are only ten data points per
timepoint and this is insufficient to make a correlation. In addition, the relationship in the first
28 days is limited by the IgG rising more slowly than the Elispot response, the latter plateauing
by Day 21 (Fig 3, panel A), whilst IgG responses to infections are generally believed to peak
later at around 4 to 6 weeks [37].
We also investigated the relationship of cellular immune responses to O. tsutsugamushi and
bacterial load in blood (expressed as AUC of bacteremia) at Day 14, which corresponds to the
peak bacteremia phase in this model, and found an inverse correlation, with increased SFCs
/106 PBMC relating to lower bacterial loads (Fig 3, panel B).
Measurement by ex-vivo IFN-γ ELISpot of cellular immune responses to
O. tsutsugamushi in human populations
In order to explore the feasibility of using this assay in human populations, responses to
OT-WCA were measured in patients participating in a study of immune responses to a differ-
ent disease (melioidosis). Subjects living in the scrub typhus endemic region of Ubon Ratch-
athani, Northeast Thailand (n = 105), had a mean IFN-γ ELISpot response of 189 SFC / 106
PBMC (95% CI 88–290), compared to 40 SFC / 106 PBMC (95% CI 9–71) in subjects living in
a non scrub typhus endemic area (Bangkok, Thailand, n = 14) some of whom may have grown
up in or travelled to an endemic part of Thailand, and 3 SFC / 106 PBMC (95% CI 0–7) for sub-
jects in Oxford, UK (n = 12) who had never encountered scrub typhus. 17/105 subjects (16%)
in the endemic region had high responses greater than 200 SFC / 106 PBMC compared to
none in the non-endemic and naïve regions (Fig 4, panel A). No differences between groups
were seen for responses to a control panel of common T-cell epitopes for Epstein–Barr virus
(EBV), cytomegalovirus (CMV), influenza etc (“T-cell control panel”, Fig 4, panel A). Provi-
sional studies showed that ELISpot counts were greatly reduced in responders if cryopreserved
PBMC rather than fresh PBMC were used, suggesting a requirement for fresh antigen present-
ing cells to optimally process whole bacteria. As for the macaque model, we saw a correlation
between the magnitude of the cellular response and the reciprocal titers of the IgG-based IFAs
in the non-human primate model (Spearman’s R = 0.57, P < 0.001 by Spearman’s rank test)
(Fig 4, panel B).
When cellular immune responses to OT-WCA antigen measured by ex vivo IFN-γ ELISpot
were compared between humans with either an IFA IgG titer of 1:400 or above (n = 22) or less
than 1:400 (n = 84), significantly higher cellular immune responses were found in people with
the higher IFA (Fig 4, panel C).
Discussion
We have established a highly sensitive method for measuring the magnitude and kinetics of
the adaptive cellular immune response to scrub typhus in rhesus macaque monkeys. This
study builds on previous work demonstrating production of IFN-γ in the host defense against
O. tsutsugamushi. The OT-WCA ELISpot assay was developed using PBMC from rhesus
Scrub typhus cellular immunity via Elispot assay
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Fig 3. Relationship between the cellular response to O. tsutsugamushi in macaques measured by ex vivo IFN-γ ELISpot, the reciprocal
titers of the IgG-based IFAs and bacteraemia. Panel A: The relationship between scrub typhus IgG antibody titer as determined by serum IFA
reciprocal titers and cellular immune responses to OT-WCA antigen (as SFC /106 PBMC) measured by ex-vivo IFN-γ ELISpot is shown for all 50
datapoints in the macaque model (top panel), and then separately for each timepoint (Day 0, 7, 14, 21 and 28). Scatter plot with linear regression line is
plotted with Spearman’s R when significant. Panel B shows the negative correlation of the cellular immune responses to O. tsutsugamushi (SFC/106
PBMC) and bacterial loads in blood (expressed as AUC of bacteremia) at Day 14, which corresponds to the peak bacteremia phase in this model.
https://doi.org/10.1371/journal.pntd.0005846.g003
Fig 4. Human cellular immune responses measured by ex vivo IFN-γ ELISpot. Panel A shows human cellular immune responses measured by ex
vivo IFN-γ ELISpot to OT-WCA and control panel of T-cell epitopes in people living in a region of Thailand endemic for scrub typhus (Ubon, n = 105), in a
non-endemic area of Thailand where some of the population have had previous exposure (Bangkok, n = 14), and in the UK where there is no scrub
typhus (Oxford, n = 12). Data is displayed as mean and 95% confidence intervals. Differences between groups were defined using the Mann-Whitney U
test. ****P < 0.0001, ***P < 0.001, ns = not significant. Panel B shows the positive correlation of scrub typhus IgG antibody titer as determined by
serum IFA reciprocal titers and cellular immune responses to OT-WCA antigen (as SFC /106 PBMC) measured by ex-vivo IFN-γ ELISpot (n = 106).
Scatter plot with linear regression line are plotted with Spearman’s R 0.57, p0.0001. Panel C shows the comparison of cellular immune responses to
OT-WCA antigen measured by ex-vivo IFN-γ ELISpot between people showing IgG IFA titers 1:400 (n = 22) and < 1:400 (n = 84). Data plotted with
mean and 95% confidence intervals. Differences between groups assessed by Mann-Whitney U test.
https://doi.org/10.1371/journal.pntd.0005846.g004
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macaques (Macaca mulatta), the most commonly used NHP model for preclinical vaccine
development. To evaluate antigen-specific cellular responses to Orientia after infection with O.
tsutsugamushi strain Karp, freshly isolated PBMC from a total of ten O. tsutsugamushi infected
rhesus macaques and five uninfected control macaques were tested with the novel ELISpot
assay from Day 0 through Day 28. O. tsutsugamushi-specific IFN-γ responses were observed
post infection from all infected macaques compared uninfected macaques, with a 20-fold
(mean 235, 95% CI 200–270 SFC/106 PBMC) increase at Day 7, a 100-fold increase at Day 14
and maintenance of high level responses to the end of the study (Day 28). The maximum mea-
surable response was limited by the SmartCount™ software, which does not read any higher
once a blackout of the well is obtained. No significant increases in cellular responses were
found in the uninfected control group at any time point. Preliminary human studies in sub-
jects from an endemic area, a non-endemic area where some of the population has previous
exposure, and from non-exposed subjects gives support to the specificity of this assay for
studying human populations, although the role of cross-reactivity to other rickettsial group
pathogens merits further exploration.
The major reason for developing the IFN-γ ELISpot assay for O. tsutsugamushi is to allow
immunogenicity monitoring in animal models, in scrub typhus exposed but healthy populations,
in patient populations, and for future vaccine trials. IFN-γ was chosen as the read-out cytokine
because of previous work demonstrating IFN-γ responses in scrub typhus patients [10–13] and
mouse studies [14, 15]. The inverse relationship seen in this study for macaques 14 days post
infection, where higher IFN- γ responses are associated with lower bacterial loads also lends sup-
port for the importance of the IFN-γ response in control of the bacteria, although other factors
such as sicker animals having lower immune responses may be relevant. The importance of IFN-
γ in response to intracellular pathogens has been reaffirmed recently by transcriptomic studies
[38–40], and by a study demonstrating the link between BCG-specific T cells secreting IFN-γ
and reduced risk of developing tuberculosis in South African infants [41]. However, other cyto-
kine responses are important, for example IL2 has been demonstrated in the development of
memory responses and antibodies following vaccination against malaria [42], Hepatitis B [43]
and tick-borne encephalitis [44]. Further studies by flow cytometry of multifunctional T-cell
responses following scrub typhus infection are underway for humans and macaques.
For this initial characterization of the cellular response to Orientia, the OT-WCA was based
on a single strain of high relevance in human disease (Karp strain).The antigen used for the
IFA assay is based on pooled whole-cell antigens from three strains of O. tsutsugamushi (Karp,
Kato and Gilliam) as this is the standard assay in the field. The conventionally used IFA slides
based on the three reference strains have served over many years to document humoral
responses against single strain Orientia infections, and results have been validated via gene
sequencing methods [45, 46]. Ongoing work in the laboratory is exploring the immunogenic-
ity of different strains and culture conditions.
A potential bias to the ELISpot assay is the potential for persistent presence of live O. tsutsu-
gamushi bacteria in the PBMC of infected monkeys, driving the antigen specific response.
However, we would expect to see responses in the media only in wells of the Day 7 and 14
macaque PBMC if residual bacteria were contributing to the measurable response. The cell cul-
ture media used contains penicillin and streptomycin to limit antimicrobial contamination in
the laboratory, which may have a partial efficacy against the bacteria, but these antibiotics were
used uniformly in all samples so should not introduce bias.
Previous vaccine development studies in cynomolgus macaques [29, 30] have demonstrated
the presence of cellular immunity to two recombinant proteins derived from Karp stain O. tsu-
tsugamushi (Kp r47b and Kp r56) using a 36-hour ELISpot assay. The magnitude of the IFN-γ
responses to the whole bacteria reported in this manuscript was much higher than the levels to
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the individual proteins (range 125–800 SFC/106 PBMC), alongside a lack of responses in unex-
posed animals. This is likely to be associated with the new and modified approach to purify O.
tsutsugamushi to produce the OT-WCA suspension as described above. This OT-WCA ELI-
Spot assay therefore allows better demonstration of the cellular immunity to the whole bacte-
ria, and can be performed as a positive control alongside exploration of immunity to specific
vaccine candidate proteins such as Kp r47b and Kp r56. The magnitude of cellular immune
response seen to OT-WCA compared to reported responses to the 47 and 56 kDa proteins sug-
gest that there are other immunodominant antigens in O. tsutsugamushi for discovery as vac-
cine candidates. Stimulation with this preparation of killed O. tsutsugamushi in scrub typhus
naïve monkeys did not invoke measurable innate cellular responses by this assay, for example
from macrophages and NK cells via pattern recognition receptor pathways. This may be due
to inactivated whole cell antigen being suboptimal at this dose for induction of innate path-
ways, or involvement of other key cytokines in pattern recognition, such as TNF-α, IL-12 and
IL1β not measured by this assay. In addition, potential evasion of the host innate immune
response by O. tsutsugamushi is of interest in understanding the pathogenesis of natural infec-
tion and will be the subject of ongoing studies.
Scrub typhus diagnostics is a major difficulty for both management of patients and for epi-
demiological studies, and the lack of a clear-cut “gold standard” reference means that statistical
modeling has been required to evaluate novel alternative diagnostic tests [36]. The OT-WCA
IFN-γ ELISpot assay uses the same technology platform as the T-SPOT interferon-gamma
release assay (IGRA) developed for diagnosis of tuberculosis [47]. Due to the laboratory pro-
cessing requirements of ELISpot assays using fresh cells we do not believe there will be role for
using the OT-WCA IFN-γ ELISpot assay for real-time diagnosis and patient management of
scrub typhus in endemic areas. However, given the unexpectedly high sensitivity and potential
high specificity observed in this study, the OT-WCA IFN-γ ELISpot assay could potentially be
used as a reference standard in research studies evaluating novel diagnostics. However evalua-
tion regarding cross-reactivity with other rickettsial group bacteria and/or cross-protection in
heterologous re-infection/infection in scrub typhus are needed.
The optimization of OT-WCA preparation for antigen stimulation studies provides a way of
exploring the host response to O. tsutsugamushi by flow cytometry, thus allowing detailed char-
acterization of cell phenotype, infected cells, secretion of cytokines and pathways of response to
the bacteria. Immune-phenotyping studies of infected cells in eschar biopsies from scrub typhus
patients have demonstrated a cellular tropism of O. tsutsugamushi for antigen presenting cells
in the skin [48]. Although the ELISpot assay is a highly sensitive method for measuring cellular
responses [21, 22], this method is unable to identify the cell phenotype secreting the cytokine.
Further studies including a small volume, whole blood stimulation assay are underway to define
which cells contribute most to IFN-γ secretion, and to characterize other cytokines associated
with O. tsutsugamushi infection. This study did not address the cross-reactivity of immunity to
Karp strain compared to other bacterial strains, and cross-reactivity with other rickettsial group
bacteria in the region. Further studies are addressing this complex issue.
In summary, we have successfully developed for the first time a novel ex vivo IFN-γ ELISpot
assay to whole O. tsutsugamushi antigen. This assay will allow field immunogenicity studies,
pave the way for more detailed flow cytometry studies of response to O. tsutsugamushi antigen
and provide a link between human and animal models to enhance vaccine development.
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